AVEO

AVEO Pharmaceuticals Inc
15.00
0.00 (0.00%)
Company Name Stock Ticker Symbol Market Type
AVEO Pharmaceuticals Inc AVEO NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.00 0.0% 15.00 19:00:00
Open Price Low Price High Price Close Price Prev Close
15.00 15.00
more quote information »

Recent News

Date Time Source Heading
2/07/20239:17IHNWFeaturedAmerican Green (OTC:ERBB) Signs $12 Million Dollar Non-Binding Letter of Intent for Funding of its Cypress Chill Cannabis Grow Facility PHOENIX, AZ (January 7,
2/07/20237:00IHNWFeaturedGoldshore Intersects 9.46 g/t Au over 7.45m in the Southwest Zone
1/30/202316:08EDGARTermination of Registration of a Class of Security Under..
1/24/202306:07EDGARNotice of Effectiveness (effect)
1/24/202306:07EDGARNotice of Effectiveness (effect)
1/24/202306:07EDGARNotice of Effectiveness (effect)
1/19/202317:20EDGARStatement of Changes in Beneficial Ownership (4)
1/19/202317:17EDGARStatement of Changes in Beneficial Ownership (4)
1/19/202317:17EDGARStatement of Changes in Beneficial Ownership (4)
1/19/202317:16EDGARStatement of Changes in Beneficial Ownership (4)
1/19/202317:16EDGARStatement of Changes in Beneficial Ownership (4)
1/19/202317:05EDGARNotification Filed by National Security Exchange to Report..
1/19/202316:47EDGARPost-effective Amendment to Registration Statement (pos Am)
1/19/202316:44EDGARPost-effective Amendment to an S-8 Filing (s-8 Pos)
1/19/202316:35GLOBELG Chem Completes Acquisition of AVEO Oncology
1/18/202308:41EDGARCurrent Report Filing (8-k)
1/05/202316:59EDGARCurrent Report Filing (8-k)
12/23/202216:02EDGARAdditional Proxy Soliciting Materials (definitive) (defa14a)
12/22/202216:47EDGARStatement of Changes in Beneficial Ownership (4)
12/02/202209:07EDGARAdditional Proxy Soliciting Materials (definitive) (defa14a)
12/02/202209:05EDGARCurrent Report Filing (8-k)
11/25/202208:09EDGARProxy Statement - Merger or Acquisition (definitive)..
11/15/202208:33EDGARProxy Statement - Merger or Acquisition (preliminary)..
11/11/202217:37VWIs Mid-Cap Neurocrine Biosciences A Buy After Blowout Q3..
11/09/202223:26TRMNSVB Securities Sticks to Its Hold Rating for AVEO Pharma..
11/09/202223:16TRMNAVEO Pharma (AVEO) Receives a Hold from Robert W. Baird
11/07/202216:11EDGARQuarterly Report (10-q)
11/01/202217:02EDGARAmended Statement of Beneficial Ownership (sc 13d/a)
10/28/202217:05TRMNJonesTrading Reaffirms Their Hold Rating on AVEO Pharma..
10/24/202208:50TRMNAnalysts Conflicted on These Healthcare Names: AVEO Pharma..
10/21/202216:56EDGARStatement of Changes in Beneficial Ownership (4)
10/21/202216:54EDGARStatement of Changes in Beneficial Ownership (4)
10/21/202216:50EDGARStatement of Changes in Beneficial Ownership (4)
10/21/202216:49EDGARStatement of Changes in Beneficial Ownership (4)
10/21/202216:48EDGARStatement of Changes in Beneficial Ownership (4)
10/21/202216:45EDGARStatement of Changes in Beneficial Ownership (4)
10/21/202216:42EDGARStatement of Changes in Beneficial Ownership (4)
10/21/202216:37EDGARStatement of Changes in Beneficial Ownership (4)
10/18/202215:15DJNAVEO Pharma Shares Soar After LG Chem Takeover News
10/18/202213:45TRMNH.C. Wainwright downgrades AVEO Pharma (AVEO) to a Hold
10/18/202207:54TRMNAVEO Soars on LG Chem Deal
10/18/202207:35TRMNJonesTrading Keeps Their Buy Rating on AVEO Pharma (AVEO)
10/18/202206:26DJNAVEO Pharmaceuticals Shares Soar on Takeover by LG Chem
10/18/202206:05DJNLG Chem to Acquire AVEO Pharmaceuticals for $566 Million
10/14/202200:05TRMNAVEO Pharma (AVEO) Gets a Buy from Robert W. Baird
10/13/202223:55TRMNAVEO Pharma (AVEO) Receives a Buy from SVB Securities
8/09/202216:38EDGARCurrent Report Filing (8-k)
8/05/202206:00EDGARSecurities Registration: Employee Benefit Plan (s-8)
8/04/202217:31EDGARQuarterly Report (10-q)
8/04/202216:25EDGARCurrent Report Filing (8-k)
6/22/202208:49DJNAVEO Oncology in Collaboration, Supply Agreement With Eli..
6/21/202209:30TRMNAnalysts Offer Insights on Healthcare Companies: SQZ..